Clinical trial

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NCT02080650

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-03-01

PhaseNA

Study timeline

Study start (unknown)2014-03-01Date precision: month

Registry last updated2017-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Renal Cell Carcinomaunresolved

Bladder Cancerunresolved

Colorectal Cancerunresolved

Gastric Cancerunresolved

Pancreatic Cancerunresolved

Non-small Cell Lung Cancerunresolved

Advanced MET Amplified Solid Tumorunresolved

Interventions

Mesenchymal-marker based ferrofluid (c-MET)DEVICE

Epithelial cell adhesion molecule (EpCAM) ferrofluidDEVICE

Sponsors & collaborators

Duke Universitylead sponsor

Prostate Cancer Foundationcollaborator

Janssen Diagnostics, LLCcollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02080650 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.